AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹65 Cr | ₹-560 Cr | ₹-74 Cr | ₹-282 Cr | ₹-224 Cr |
What is the latest Cash Flow from Investing Activities ratio of AJANTA PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹65 Cr |
Mar2023 | ₹-560 Cr |
Mar2022 | ₹-74 Cr |
Mar2021 | ₹-282 Cr |
Mar2020 | ₹-224 Cr |
How is Cash Flow from Investing Activities of AJANTA PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹65 Cr | Positive | |
Mar2023 | ₹-560 Cr | Negative | |
Mar2022 | ₹-74 Cr | Negative | |
Mar2021 | ₹-282 Cr | Negative | |
Mar2020 | ₹-224 Cr | - |
Compare Cash Flow from Investing Activities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹33,590.6 Cr | -10% | -5.2% | 19.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -10% |
-5.2% |
19.6% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses